Nebenwirkungen · Bronchitol
Bronchitol 40 mg inhalation powder, hard capsules · Abschnitt 4.8 · PDF-Seite 6
HOS-123861 · Präparat HOS-095743
The most important adverse reaction associated with the use of Bronchitol is haemoptysis. The proportion of patients who experienced haemoptysis as an adverse reaction was 7.3%, 3.3% and 3.4% in the Bronchitol arms for studies 301, 302 and 303 respectively vs. 3.4%, 0% and 5.6% in the control arms. The proportion of patients who experienced haemoptysis including haemoptysis reported during exacerbation was 7.0% in the mannitol arm and 7.7% in the control arm (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-17T11:15:00Z · SHA-256 1497498c39a8a80b066fda0fa1de415d5889e573bca29c63d440827f97a70292 · Passage 7aae3b49f0e1dd3bd918ca19d459f8e22b7f679ea9a179a6891a9a3b08b8495b · Zeichen 918–1399 im Abschnitt